|
|
| Médicaments En Vente Libre > Etude de marché sectorielle |
| Generics: Global Industry Guide |
|
|
|
|
€ 796,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Décembre 2006 |
Taille du document : |
159 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (2) |
|
|
|
| 55 pages | Décembre 2003 | Anglais
|
|
|
| Main
focus: |
pharmaceutical,therapeutic classes,pharmaceuticals,...,...
|
| Research
focus: |
market size and estimates,market outlook, |
| Geographic
focus: |
usa,canada,india,china,mexico,japan,philippines,... |
| |
|
|
|
|
| 47 pages | Mai 2007 | Anglais
|
|
|
| Main
focus: |
generics,pharmaceutical,pharmaceuticals,...
|
| Research
focus: |
market size and estimates,market outlook, |
| Geographic
focus: |
usa,germany,canada,france,united kingdom,italy,... |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
US Contraceptives 2004 12 pages | Novembre 2004 |
Snapdata's US Contraceptives 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US contraceptive market, and co |
240,00 €
|
| |
| |
US Sleeping Remedies 2004 12 pages | Novembre 2004 |
Snapdata's US Sleeping Remedies 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US sleeping remedy market.
|
240,00 €
|
| |
| |
US Hair Growth Products 2004 12 pages | Juillet 2004 |
Snapdata's US Hair Growth Products 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US hair growth product ma |
240,00 €
|
| |
| |
France OTC Pharmaceuticals 2004 12 pages | Décembre 2004 |
Snapdata's France OTC Pharmaceuticals 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the French OTC pharmaceuti |
240,00 €
|
| |
| |
Poland OTC Pharmaceuticals 2004 11 pages | Juillet 2004 |
Snapdata's Poland OTC Pharmaceuticals 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the Polish OTC pharmaceuti |
240,00 €
|
| |
| |
US Internal Analgesics 2004 14 pages | Juillet 2004 |
Snapdata's US Internal Analgesics 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US internal analgesic mark |
240,00 €
|
| |
| |
US Vitamins & Minerals 2004 13 pages | Novembre 2004 |
Snapdata's US Vitamins & Minerals 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US vitamin and mineral mar |
240,00 €
|
| |
| |
US Eye & Contact Lens Care 2004 14 pages | Juillet 2004 |
Snapdata's US Eye & Contact Lens Care 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US eye and contact len |
240,00 €
|
| |
| |
UK Vitamin & Dietary Supplements 2004 12 pages | Juillet 2004 |
Snapdata's UK Vitamin & Dietary Supplements 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the UK vitamin and d |
240,00 €
|
| |
| |
UK Smoking Cessation Aids 2004 12 pages | Juillet 2004 |
Snapdata's UK Smoking Cessation Aids 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the UK smoking cessation ai |
240,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Generics: Global Industry Guide |
|
|
Datamonitor's Generics: Global Industry Guide is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.
Scope of the Report * Contains an executive summary and data on value and segmentation * Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies * Covers Global, European, Asia-Pacific & 11 individual country markets * Includes a five-year forecast of the industry
Highlights
The global generics market generated total revenues of $57.8 billion in 2005, an increase of 20.9% since 2004, representing a compound annual growth rate (CAGR) of 18.2% for the five-year period spanning 2001-2005.
Ethical generic sales proved the most lucrative for the global market in 2005, generating total revenues of $44.3 billion, equivalent to 76.6% of the market‘s overall value.
Looking forward, the market is forecast to grow at a very healthy rate and improve its performance, with an anticipated CAGR of 16% for the five-year period 2005-2010 expected to drive the market to a value of $121.3 billion by the end of 2010.
Why you should buy this report: * Spot future trends and developments * Inform your business decisions * Add weight to presentations and marketing materials * Save time carrying out entry-level research
Definition
The value of the generics market consists of all sales of generics drugs at exmanufacturers prices. The market does not include consumer healthcare products, nor animal healthcare. Datamonitor defines a generic as a product, which is an officially approved copy of an original product whose patent has expired, marketed either as a brand or using the generic name. This definition excludes multi-source copy products that make up much of markets such as India, Spain and Italy. All currency conversions have been calculated at constant 2005 average exchange rates.
For the purpose of this report, Europe is deemed to consist of Belgium, France, Germany, Italy, Netherlands, Spain and the UK.
Asia-Pacific consists of the Chinese and Japanese markets.
The Americas is composed of Canada and the United States.
The global market is deemed to be Asia-Pacific, Europe and the Americas.
|
|
Generics: Global Industry Guide
|
|
|
PPLSEN
|
|
|
|
|